How to Get Evusheld Therapy in Boise

After years of accelerated research by pharmaceutical companies, clients have access to more preventative measures against COVID-19 than ever before.

In particular, Evusheld therapy is amongst the most promising.

What is Evusheld therapy?

Also known as pre-exposure prophylaxis (PfEP), Evusheld is made up of two medications that act as long-acting antibodies within your system to ward off infection from COVID-19.

Benefits of Evusheld

While not a replacement for the vaccine, it can be viewed as an additional barrier of protection clients can utilize.

Initial research from AstraZeneca has indicated it is very effective against mutated strains, including Omicron. The data also indicated patients experienced a 77% reduction in risk of infection for up to six months after treatment.

Who should receive it?

No one is excluded from receiving this treatment protocol; however, consulting with your medical provider is always encouraged.

Evusheld was initially designed as an alternative for individuals that could not take the vaccine. This includes people with compromised immune systems, allergic reactions to the vaccine, or who are taking immune suppressant medication.

Can I receive at-home Evusheld treatment in Boise?

While residents can receive in-clinic treatment, many in Boise opt for in-home treatment.

This is understandable, considering ideal candidates for treatment would benefit from limited potential exposure to new places.

Consultations are done virtually, and a medical professional accompanies them to administer treatment. In-home personalized care has many advantages that Boise residents see as the superior option for their Evusheld treatment.

Source:

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

Evusheld Antibody Therapy with Drip Hydration

Authorized by the FDA under the emergency use authorization (EUA), EVUSHELD is a treatment that may prevent COVID-19 in eligible individuals.

EVUSHELD is a monoclonal antibody therapy that aims to prevent COVID-19 in adults and adolescents aged 12 and over who meet eligibility criteria. A single dose that consists of two separate injections provides long-lasting protection against the COVID-19 virus in individuals who are not currently infected with the virus.

Appointments only take a few minutes. One of our registered nurses will come to your location to administer the injection. Contact us today to get started!